Worldâs most expensive mushroom to receive GI in India
20-01-2021
13-07-2018
One of the world’s most expensive mushrooms may soon receive protection in the form of a geographical indication (GI) in India.
Indian business news outlet Business Line announced the news on Sunday, January 17.
The mushroom, known as ‘Gucchi’ or ‘Morel’, is grown in India’s Doda district in the territory of Jammu and Kashmir. Jammu and Kashmir’s Department of Agriculture has reportedly filed an application to secure GI protection for Gucchi.
Fetching more than â¹20,000 ($273) per kilogram, Gucchi is one of the costliest mushrooms in the world. Around 45 tonnes of the product is produced annually in Jammu and Kashmir. It tends to be collected by farmers and tribesmen around March after the snow has melted.
South Africa and India argued in favour of a waiver of intellectual property rights on COVID-19 drugs and vaccines at a closed-door meeting of the World Trade Organization on Tuesday but opponents showed little sign of budging, trade sources said.
Dummy s guide to how trade rules affects the access to COVID-19 vaccines
There is an urgent need to clarify public interest and public health exceptions to TRIPS intellectual property rights.
Jan 18, 2021 13:14:05 IST
The race is on to secure vaccines that will protect people from COVID-19. But it’s already become apparent that there is gross inequality playing out in the procurement and distribution of the new drugs. One reason is intellectual property rights. The World Trade Organisation (WTO) is considering whether to temporarily waive certain rules about Trade-Related Aspects of Intellectual Property Rights (TRIPS), so as to allow more countries access to vaccines, drugs, and medical technologies needed to prevent, contain, or treat COVID-19. Initially proposed by South Africa and India, the waiver has the support of almost 100 developing countries, scores of international NGOs, several UN agencies, and the Director-General of the World Health Organisation. But there is opp
Activists are running a campaign called the People’s Vaccine Campaign
The AU has managed to sure 270 million doses for the continent
The C19 People’s Coalition is calling on the South African government for urgent mobilisation and equitable vaccine access and allocation. The coalition’s call for a People’s Vaccine Campaign has been endorsed by over 500 organisations.
The call for a people’s vaccine
The activists say that South Africa s unequal healthcare system is one of the driving forces for this campaign. They say that the majority of South Africa s people, who are mainly black and poor, should not be denied access to the vaccine, with a collaborative effort from government and manufacturers to ensure that delivery of the vaccine is free from predatory and profiteering practices.
The WTO is considering whether to temporarily waive certain rules about Trade-Related Aspects of Intellectual Property Rights (TRIPS), so as to allow more countries access to vaccines.